Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
98.50
+7.25 (7.95%)
At close: May 12, 2025, 4:00 PM
98.50
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | 2013 - 2019 |
| Discovery & Analytical Solutions Product Revenue (Pre-Q3 2022) |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Discovery & Analytical Solutions Product Revenue (Pre-Q3 2022) Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Discovery & Analytical Solutions Service Revenue (Pre-Q3 2022) |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Discovery & Analytical Solutions Service Revenue (Pre-Q3 2022) Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Discovery & Analytical Solutions Revenue (Pre-Q3 2022) |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Discovery & Analytical Solutions Revenue (Pre-Q3 2022) Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Product Revenue (Pre-Q3 2022) |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Product Revenue (Pre-Q3 2022) Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Service Revenue (Pre-Q3 2022) |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Service Revenue (Pre-Q3 2022) Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Discovery & Analytical Solutions Revenue (Post-Q2 2022) |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Discovery & Analytical Solutions Revenue (Post-Q2 2022) Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Diagnostics Revenue (Pre-Q3 2022) |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Diagnostics Revenue (Pre-Q3 2022) Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Product |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Product Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Service |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Service Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Revenue (Pre-Q3 2022) |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Life Sciences Revenue (Pre-Q3 2022) Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Applied Markets Revenue (Pre-Q3 2022) |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Applied Markets Revenue (Pre-Q3 2022) Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2013 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | 2013 - 2019 |
| Discovery & Analytical Solutions Operating Income (Pre-Q3 2022) |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Discovery & Analytical Solutions Operating Income (Pre-Q3 2022) Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Discovery & Analytical Solutions Operating Income (Post-Q2 2022) |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Discovery & Analytical Solutions Operating Income (Post-Q2 2022) Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Operating Income (Pre-Q3 2022) |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Operating Income (Pre-Q3 2022) Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|